Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 10,351 shares of the company’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $2.71, for a total transaction of $28,051.21. Following the transaction, the chief executive officer owned 146,288 shares in the company, valued at $396,440.48. The trade was a 6.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.
Amit Gupta also recently made the following trade(s):
- On Friday, October 2nd, Amit Gupta sold 7,382 shares of Cardlytics stock. The shares were sold at an average price of $2.53, for a total transaction of $18,676.46.
- On Tuesday, August 18th, Amit Gupta sold 6,676 shares of Cardlytics stock. The shares were sold at an average price of $4.03, for a total transaction of $26,904.28.
- On Monday, August 17th, Amit Gupta sold 6,785 shares of Cardlytics stock. The stock was sold at an average price of $3.97, for a total transaction of $26,936.45.
- On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total transaction of $42,319.60.
Cardlytics Stock Down 4.2%
NASDAQ:CDLX traded down $0.11 during trading hours on Friday, hitting $2.53. 75,648 shares of the stock were exchanged, compared to its average volume of 84,032. The company has a market capitalization of $14.70 million, a P/E ratio of -0.14 and a beta of 0.71. The company’s 50 day moving average is $3.83 and its two-hundred day moving average is $5.90. Cardlytics, Inc. has a twelve month low of $2.47 and a twelve month high of $26.70.
Institutional Investors Weigh In On Cardlytics
A hedge fund recently bought a new stake in Cardlytics stock. Worldly Partners Management LLC bought a new stake in Cardlytics, Inc. (NASDAQ:CDLX – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 115,798 shares of the company’s stock, valued at approximately $520,000. Cardlytics accounts for about 0.4% of Worldly Partners Management LLC’s holdings, making the stock its 3rd biggest position. Worldly Partners Management LLC owned 1.99% of Cardlytics as of its most recent filing with the Securities and Exchange Commission (SEC). 68.10% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on CDLX shares. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Thursday, June 18th. Weiss Ratings restated a “sell (e+)” rating on shares of Cardlytics in a research report on Wednesday, July 8th. Finally, Wall Street Zen downgraded shares of Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, September 19th. One equities research analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Sell” and an average price target of $10.00.
View Our Latest Stock Report on CDLX
About Cardlytics
Cardlytics, Inc is an advertising technology company that connects marketers with consumers through financial institutions. Its platform uses transaction-based insights to help advertisers reach customers with relevant offers and measure the impact of advertising on consumer spending.
Cardlytics’ services are integrated into banking and financial applications, where consumers may receive personalized cash-back offers, discounts and other promotions based on their shopping activity. Participating financial institutions can use the platform to provide additional value to customers while generating advertising revenue.
The company serves advertisers across categories such as retail, dining, travel and financial services, and works with banks and other financial institutions primarily in the United States and the United Kingdom.
See Also
- Five stocks we like better than Cardlytics
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
